Skip to main content

Advertisement

Log in

pcDNA3.1tdTomato Is Superior to pDsRed2-N1 for Optical Fluorescence Imaging in the F344/AY-27 Rat Model of Bladder Cancer

  • Research Article
  • Published:
Molecular Imaging and Biology Aims and scope Submit manuscript

Abstract

Purpose

Animal models are important for pre-clinical assessment of novel therapies in metastatic bladder cancer. The F344/AY-27 model involves orthotopic colonisation with AY-27 tumour cells which are syngeneic to F344 rats. One disadvantage of the model is the unknown status of colonisation between instillation and sacrifice. Non-invasive optical imaging using red fluorescence reporters could potentially detect tumours in situ and would also reduce the number of animals required for each experiment.

Materials and Methods

AY-27 cells were stably transfected with either pDsRed2-N1 or pcDNA3.1tdTomato. The intensity and stability of fluorescence in the resultant AY-27/DsRed2-N1 and AY-27/tdTomato stable cell lines were compared using Xenogen IVIS®200 and Olympus IX51 systems.

Results

AY-27/tdTomato fluorescence intensity was 60-fold brighter than AY­27/DsRed2-N1 and was sustained in AY-27/tdTomato cells following freezing and six subsequent sub-cultures. After sub-cutaneous injection, fluorescence intensity from AY-27/tdTomato cells was threefold stronger than that detected from AY-27/DsRed2-N1 cells. IVIS®200 detected fluorescence from AY-27/tdTomato and AY-27/DsRed2-N1 cells colonising resected and exteriorised bladders, respectively. However, the deep-seated position of the bladder precluded in vivo imaging. Characteristics of AY-27/tdTomato cells in vitro and in tumours colonising F344 rats resembled those of parental AY-27 cells. Tumour transformation was observed in the bladders colonised with AY-27/DsRed2-N1 cells.

Conclusions

In vivo whole-body imaging of internal red fluorescent animal tumours should use pcDNA3.1tdTomato rather than pDsRed2-N1. Optical imaging of deep-seated organs in larger animals remains a challenge which may require proteins with brighter red or far-red fluorescence and/or alternative approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Xiao Z, McCallum TJ, Brown KM et al (1999) Characterization of a novel transplantable orthotopic rat bladder transitional cell tumor model. Br J Cancer 81:638–646

    Article  CAS  PubMed  Google Scholar 

  2. Asanuma H, Arai T, Seguchi K et al (2003) Successful diagnosis of orthotopic rat superficial bladder tumor by ultrathin cystoscopy. J Urol 169:718–720

    Article  PubMed  Google Scholar 

  3. Yang M, Jiang P, Yamamoto N et al (2005) Real-time whole-body imaging of an orthotopic metastatic prostate cancer model expressing red fluorescent protein. Prostate 62:374–379

    Article  PubMed  Google Scholar 

  4. Winnard PT, Kluth JB, Raman V (2006) Noninvasive optical tracking of red fluorescent protein-expressing cancer cells in a model of metastatic breast cancer. Neoplasia 8:796–806

    Article  CAS  PubMed  Google Scholar 

  5. Gross LA, Baird GS, Hoffman RC et al (2000) The structure of the chromophore within DsRed, a red fluorescent protein from coral. Proc Natl Acad Sci USA 97:11990–11995

    Article  CAS  PubMed  Google Scholar 

  6. Shaner NC, Steinbach PA, Tsien RY (2005) A guide to choosing fluorescent proteins. Nat Methods 2:905–909

    Article  CAS  PubMed  Google Scholar 

  7. Zhou J-H, Rosser CJ, Tanaka M et al (2002) Visualizing superficial human bladder cancer cell growth in vivo by green fluorescent protein expression. Cancer Gene Therapy 9:681–686

    Article  CAS  PubMed  Google Scholar 

  8. Yang M, Luiken G, Baranov E, Hoffman RM (2005) Biotechniques 39:170–172

    Article  CAS  PubMed  Google Scholar 

  9. Hoffman RM (2005) The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat Rev Cancer 5:796–806

    Article  CAS  PubMed  Google Scholar 

  10. Hoffman RM, Yang M (2006) Whole-body imaging with fluorescent proteins. Nature Protocols 1:1429–1438

    Article  CAS  PubMed  Google Scholar 

  11. Weber J, Weberova J, Carobene M et al (2006) Use of a novel assay based on intact recombinant viruses expressing green (EGFP) or red (DsRed2) fluorescent proteins to examine the contribution of pol and env genes to overall HIV-1 replicative fitness. J Virol Methods 136:102–117

    Article  CAS  PubMed  Google Scholar 

  12. Seitz G, Warmann SW, Fuchs J et al (2006) Visualization of xenotransplanted human rhabdomyosarcoma after transfection with red fluorescent protein. J Pediatr Surg 41:1369–1376

    Article  PubMed  Google Scholar 

  13. Hadjantonakis AK, Papaioannou VE (2004) Dynamic in vivo imaging and cell tracking using a histone fluorescent protein fusion in mice. BMC Biotechnol 4:33

    Article  PubMed  Google Scholar 

  14. Maruyama M, Nishio T, Yoshida T et al (2004) Simultaneous detection of DsRed2-tagged and EGFP-tagged human beta-interferons in the same single cells. J Cell Biochem 93:497–502

    Article  CAS  PubMed  Google Scholar 

  15. Harris AL, Neal DE (1992) Bladder cancer—field versus clonal origin. N Engl J Med 326:759–769

    Article  CAS  PubMed  Google Scholar 

  16. Campbell RE, Tour O, Palmer AE et al (2002) A monomeric red fluorescent protein. Proc Natl Acad Sci USA 99:7877–7882

    Article  CAS  PubMed  Google Scholar 

  17. Bevis BJ, Glick BS (2002) Rapidly maturing variants of the Discosoma red fluorescent protein (DsRed). Nat Biotechnol 20:83–87

    Article  CAS  PubMed  Google Scholar 

  18. Scherbo D, Merzlyak EM, Chepurnykh TV et al (2007) Bright far-red fluorescent protein for whole-body imaging. Nat Methods 4:741–746

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank Professor Roger Tsien (University California of San Diego, USA) for the kind gift of the tdTomato gene in pRSET-B vector. This project has been funded by Research and Development Offices, HPSS Northern Ireland (AL); Mason’s Medical Foundation (VK); Egyptian Cultural Bureau (OS); Department of Employment and Learning (CW). We would like to thank Mr. Ken Arthur for his help with DNA flow cytometry.

Ethical Approval

All animal studies described in this manuscript were conducted according to Animal Licencing guidelines and approval.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kate Williamson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koo, V., Lee, A., Sharaf Eldin, O. et al. pcDNA3.1tdTomato Is Superior to pDsRed2-N1 for Optical Fluorescence Imaging in the F344/AY-27 Rat Model of Bladder Cancer. Mol Imaging Biol 12, 509–519 (2010). https://doi.org/10.1007/s11307-009-0275-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11307-009-0275-3

Key words

Navigation